Advertisement
Advertisement
U.S. Markets close in 2 hrs 27 mins
Advertisement
Advertisement
Advertisement
Advertisement

Milestone Scientific Inc. (MLSS)

NYSE American - Nasdaq Real Time Price. Currency in USD
Add to watchlist
0.8400+0.1300 (+18.31%)
As of 01:31PM EDT. Market open.
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.7100
Open0.6900
Bid0.8177 x 900
Ask0.8600 x 900
Day's Range0.7000 - 0.8640
52 Week Range0.6300 - 3.0000
Volume137,374
Avg. Volume70,382
Market Cap56.991M
Beta (5Y Monthly)1.36
PE Ratio (TTM)N/A
EPS (TTM)-0.1190
Earnings DateNov 14, 2022 - Nov 18, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est4.00
  • GlobeNewswire

    Milestone Scientific Commences Sales of CompuFlo® Epidural Disposables Across Three Departments within UofL Health

    ROSELAND, N.J., Aug. 18, 2022 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today reported that, following a successful evaluation, it has commenced sales of its CompuFlo® Epidural disposables to UofL Health (University of Louisville), a leading academic health system based in Louisville, Kentucky. UofL Health owns and operates six hospitals and four medical centers, providin

  • GlobeNewswire

    Milestone Scientific Provides Business Update for the Second Quarter of 2022

    ROSELAND, N.J., Aug. 16, 2022 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today provided a business update and announced financial results for the second quarter ended June 30, 2022. Arjan Haverhals, CEO and President of Milestone Scientific, stated, “We have made significant progress rolling out our CompuFlo® Epidural System. Specifically, we have commenced sales in key ho

  • GlobeNewswire

    Milestone Scientific Schedules Second Quarter 2022 Financial Results and Business Update Conference Call

    ROSELAND, N.J., Aug. 12, 2022 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today announced that it will host a conference call at 8:30 AM Eastern Time on Tuesday, August 16, 2022, to discuss the company’s financial results for the second quarter ended June 30, 2022, as well as the company’s corporate progress and other developments. The conference call will be available via

Advertisement
Advertisement